SULT1A4
Basic information
Region (hg38): 16:29459913-29464966
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SULT1A4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 1 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 1 | 1 | 0 |
Variants in SULT1A4
This is a list of pathogenic ClinVar variants found in the SULT1A4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-29461411-G-A | not specified | Uncertain significance (Aug 14, 2024) | ||
16-29461427-C-T | Likely benign (Nov 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SULT1A4 | protein_coding | protein_coding | ENST00000395400 | 7 | 9174 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.385 | 0.486 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.980 | 3 | 12.9 | 0.232 | 6.65e-7 | 1898 |
Missense in Polyphen | 0 | 3.3471 | 0 | 730 | ||
Synonymous | 0.476 | 5 | 6.55 | 0.763 | 3.99e-7 | 530 |
Loss of Function | 0.893 | 0 | 0.928 | 0.00 | 3.94e-8 | 164 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of phenolic monoamines (neurotransmitters such as dopamine, norepinephrine and serotonin) and phenolic and catechol drugs.;
- Pathway
- Chemical carcinogenesis - Homo sapiens (human);Pathway_PA165986194 -need delete;Acetaminophen Pathway, Pharmacokinetics;Acetaminophen Metabolism Pathway;Sulfation Biotransformation Reaction;Metapathway biotransformation Phase I and II;Phase II - Conjugation of compounds;dopamine degradation;Biological oxidations;Metabolism;Cytosolic sulfonation of small molecules;serotonin degradation;superpathway of tryptophan utilization
(Consensus)
Recessive Scores
- pRec
- 0.172
Haploinsufficiency Scores
- pHI
- 0.908
- hipred
- N
- hipred_score
- 0.139
- ghis
- 0.429
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.207
Gene ontology
- Biological process
- catecholamine metabolic process;steroid metabolic process;3'-phosphoadenosine 5'-phosphosulfate metabolic process
- Cellular component
- cytosol
- Molecular function
- aryl sulfotransferase activity